Login / Signup

Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma" by Giovanni Barosi and Robert Peter Gale.

Sarah A HolsteinVera J SumanPhilip L McCarthy
Published in: Leukemia (2019)
Keyphrases
  • multiple myeloma
  • newly diagnosed
  • healthcare
  • single cell
  • palliative care
  • cell therapy
  • quality improvement
  • stem cell transplantation
  • pain management
  • stem cells
  • affordable care act
  • low dose
  • health insurance